MedPath
NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

国药准字HJ20230099

August 8, 2023

Drug Information

奥美沙坦酯氨氯地平片

片剂

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg(以氨氯地平计)

化学药品

August 8, 2023

August 7, 2028

Company Information

Applicant Company

Unit-Ⅶ, SEZ, TSIIC, Plot No. S1, Survey No's: 411/P, 425/P, 434/P, 435/P & 458/P, Green Industrial Park, Polepally Village, Jedcherla Mandal, Mahaboobnagar District, Telangana State, India.

Manufacturing Company

Unit-Ⅶ, SEZ, TSIIC, Plot No. S1, Survey No's: 411/P, 425/P, 434/P, 435/P & 458/P, Green Industrial Park, Polepally Village, Jedcherla Mandal, Mahaboobnagar District, Telangana State, India.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氨氯地平片 - NMPA 批准文号 | MedPath